UVM MC
Welcome,         Profile    Billing    Logout  
 6 Trials 
11 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Smith, Lisa
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
NCT03819387: A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer

Completed
1
49
US
NBF-006
Nitto BioPharma, Inc.
Non-Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer
11/23
03/24
NCT04661163: CHALLENGE. A Randomised Clinical Trial Examining Virtual Reality Therapy

Completed
N/A
270
Europe
Psychotherapy, Virtual Reality Avatar Therapy
Mental Health Services in the Capital Region, Denmark, Mental Health Services in the Region of Southern Denmark, Mental Health Services in the North Denmark Region
Auditory Hallucinations
02/24
04/24
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk

Recruiting
N/A
2500
US
Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test
Exact Sciences Corporation
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer
01/25
04/26
Darby, Gwendolyn
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
SHINE, NCT06425159: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Idiopathic Generalized Epilepsy With Generalized Tonic-clonic Seizures

Recruiting
2/3
242
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Generalized Epilepsy
07/26
07/27
Thompson, Stacy
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
NCT05605301: Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy

Completed
2
9
US
Oral 2-Deoxy-D-Glucose (2DG)
University of Virginia, Epilepsy Foundation, University of Wisconsin, Madison
Epilepsy; Seizure
02/24
02/24
NCT02804230: MR-Guided Focused Ultrasound in the Treatment of Focal Epilepsy (EP001)

Recruiting
N/A
20
US
Neuro Ablation - Functional, Focused Ultrasound, MRgFUS, FUS
InSightec, Food and Drug Administration (FDA)
Epilepsy
06/23
06/23
Cooper, Kristina
RISE 2, NCT06132893: A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy

Recruiting
2/3
390
Europe, US, RoW
BHV-7000, Placebo
Biohaven Therapeutics Ltd.
Focal Epilepsy
08/25
09/25
NCT05737745: FitEx for Endometrial Cancer Survivors: Initial Efficacy

Active, not recruiting
N/A
150
US
Self-monitoring, Group-dynamics, Weekly virtual sessions- Standard, Newsletters- Standard, Newsletters- Yoga, Weekly virtual sessions- Yoga
Carilion Clinic, National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS), Virginia Polytechnic Institute and State University
Endometrial Cancer, Obesity, Sedentary Behavior, Quality of Life, Survivorship
11/23
06/24

Download Options